Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework

被引:13
作者
Dima, Alexandra L. [1 ]
Allemann, Samuel S. [2 ]
Dunbar-Jacob, Jacqueline [3 ]
Hughes, Dyfrig A. [4 ]
Vrijens, Bernard [5 ,6 ]
Wilson, Ira B. [7 ]
机构
[1] Inst Recerca St Joan de Deu, Res & Dev Unit, Barcelona, Spain
[2] Univ Basel, Pharmaceut Care Res Grp, Basel, Switzerland
[3] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA
[4] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales
[5] Univ Liege, AARDEX Grp, Liege, Belgium
[6] Univ Liege, Dept Publ Hlth, Liege, Belgium
[7] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
adherence; methodology; pharmacotherapy; RECOMMENDATIONS; VALIDATION; ROAD;
D O I
10.1111/bcp.15375
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Measuring adherence to medication is complex due to the diversity of contexts in which medications are prescribed, dispensed and used. The Timelines-Events-Objectives-Sources (TEOS) framework outlined a process to operationalize adherence. We aimed to develop practical recommendations for quantification of medication adherence using self-report (SR), electronic monitoring (EM) and electronic healthcare databases (EHD) consistent with the TEOS framework for adherence operationalization. Methods An adherence methodology working group of the International Society for Medication Adherence (ESPACOMP) analysed implications of the process of medication adherence for all data sources and discussed considerations specific to SR, EM and EHD regarding the information available on the prescribing, dispensing, recommended and actual use timelines, the four events relevant for distinguishing the adherence phases, the study objectives commonly addressed with each type of data, and the potential sources of measurement error and quality criteria applicable. Results Four key implications for medication adherence measurement are common to all data sources: adherence is a comparison between two series of events (recommended and actual use); it refers to one or more specific medication(s); it applies to regular repeated events coinciding with known recommended dosing; and it requires separate measurement of the three adherence phases for a complete picture of patients' adherence. We propose recommendations deriving from these statements, and aspects to be considered in study design when measuring adherence with SR, EM and EHD using the TEOS framework. Conclusion The quality of medication adherence estimates is the result of several design choices that may optimize the data available.
引用
收藏
页码:1918 / 1927
页数:10
相关论文
共 41 条
  • [1] A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network
    Altman, Douglas G.
    Simera, Iveta
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2016, 109 (02) : 67 - 77
  • [2] Methods for evaluation of medication adherence and persistence using automated databases
    Andrade, Susan E.
    Kahler, Kristijan H.
    Frech, Feride
    Chan, K. Arnold
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (08) : 565 - 574
  • [3] Proposal of Standardization to Assess Adherence With Medication Records: Methodology Matters
    Arnet, Isabelle
    Kooij, Marcel J.
    Messerli, Markus
    Hersberger, Kurt E.
    Heerdink, Eibert R.
    Bouvy, Marcel
    [J]. ANNALS OF PHARMACOTHERAPY, 2016, 50 (05) : 360 - 368
  • [4] Real-time monitoring technology in single-case experimental design research: Opportunities and challenges
    Bentley, Kate H.
    Kleiman, Evan M.
    Elliott, Grace
    Huffman, Jeffery C.
    Nock, Matthew K.
    [J]. BEHAVIOUR RESEARCH AND THERAPY, 2019, 117 : 87 - 96
  • [5] Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing Histories
    Blaschke, Terrence F.
    Osterberg, Lars
    Vrijens, Bernard
    Urquhart, John
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52, 2012, 52 : 275 - +
  • [6] Coming full circle in the measurement of medication adherence: opportunities and implications for health care
    Buono, Elizabeth Whalley
    Vrijens, Bernard
    Bosworth, Hayden B.
    Liu, Larry Z.
    Zullig, Leah L.
    Granger, Bradi B.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1009 - 1016
  • [7] Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments
    Chesney, MA
    Ickovics, JR
    Chambers, DB
    Gifford, AL
    Neidig, J
    Zwickl, B
    Wu, AW
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03): : 255 - 266
  • [8] ESPACOMP Medication Adherence Reporting Guideline (EMERGE)
    De Geest, Sabina
    Zullig, Leah L.
    Dunbar-Jacob, Jacqueline
    Helmy, Remon
    Hughes, Dyfrig A.
    Wilson, Ira B.
    Vrijens, Bernard
    [J]. ANNALS OF INTERNAL MEDICINE, 2018, 169 (01) : 30 - +
  • [9] TEOS: A framework for constructing operational definitions of medication adherence based on Timelines-Events-Objectives-Sources
    Dima, Alexandra L.
    Allemann, Samuel S.
    Dunbar-Jacob, Jacqueline
    Hughes, Dyfrig A.
    Vrijens, Bernard
    Wilson, Ira B.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (06) : 2521 - 2533
  • [10] Measuring medication adherence in asthma: Development of a novel self-report tool
    Dima, Alexandra L.
    van Ganse, Eric
    Laforest, Laurent
    Texier, Nathalie
    de Bruin, Marijn
    [J]. PSYCHOLOGY & HEALTH, 2017, 32 (10) : 1288 - 1307